Trial Profile
Sitagliptin Use and its Continuous Glycemic Control Effects in Japanese patients with type 2 diabetes in Saitama
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Aug 2019
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SUCCEED
- 24 Aug 2019 Status changed from recruiting to completed.
- 08 Dec 2017 Interim results (n=321) of study till 52 weeks assessing efficacy and durability of glucose and lipid metabolism, presented at the 2017 Congress of the International Diabetes Federation.
- 19 Feb 2011 New trial record